Expand LGND Menu
LGND MENU

LGND Latest Press Releases

-- December 9, 2025 --

Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance Globe Newswire 7:00 AM

-- November 10, 2025 --

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates Globe Newswire 4:10 PM

-- November 7, 2025 --

Pelthos Therapeutics Acquires Xepi (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing Globe Newswire 8:00 AM

-- November 6, 2025 --

Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance Globe Newswire 7:00 AM

-- October 30, 2025 --

Ligand to Participate in November Investor Conferences Globe Newswire 4:01 PM

-- October 23, 2025 --

Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025 Globe Newswire 7:00 AM

-- October 16, 2025 --

Ligand to Host Investor Day on December 9, 2025 Globe Newswire 7:00 AM

-- October 9, 2025 --

Ligand Partner SQ Innovation Receives FDA Approval for Lasix ONYU, an At-Home Treatment for Edema in Heart Failure Patients Globe Newswire 7:00 AM

-- September 25, 2025 --

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292 Globe Newswire 2:30 AM

-- August 19, 2025 --

Ligand to Participate in September Investor Conferences Globe Newswire 4:00 PM

-- August 14, 2025 --

Ligand Announces Closing of Convertible Senior Notes Offering Globe Newswire 4:00 PM

-- August 12, 2025 --

Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates Globe Newswire 8:14 AM

-- August 11, 2025 --

Ligand Announces Pricing of $400 Million Convertible Senior Notes Offering Globe Newswire 11:46 PM
Ligand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030 Globe Newswire 7:00 AM

-- August 7, 2025 --

Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance Globe Newswire 7:00 AM

-- August 5, 2025 --

Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings Globe Newswire 7:00 AM

-- July 31, 2025 --

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes